Today, there is a soup of different coronavirus variants causing illness and the most common ones are fairly close relatives. As expected, XBB.1.5 has faded away in the months it took to tweak the vaccine. WILL THEY BE EFFECTIVE ENOUGH? Health officials are optimistic, barring a new mutant. A CDC advisory panel is set to meet Tuesday to make recommendations on how best to use the latest shots.Įarlier this month, European regulators authorized Pfizer’s updated vaccine for this fall, for adults and children as young as 6 months. Then the CDC must sign off before vaccinations begin. The FDA will soon decide if each company has met safety, effectiveness and quality standards. Pfizer, Moderna and Novavax all have brewed new supplies. The COVID-19 vaccines offered since last year are combination shots targeting the original coronavirus strain and a much earlier omicron version, making them very outdated. The updated shots have a single target, an omicron descendant named XBB.1.5. Similar to how flu shots are updated each year, the Food and Drug Administration gave COVID-19 vaccine makers a new recipe for this fall. WHY MORE COVID-19 SHOTS? The ever-evolving coronavirus isn’t going away. Here is what you need to know about fall vaccinations: That’s why we want to get ahead of it,” CDC chief Dr. “There will be a lot of virus this winter. in “our strongest position yet” to avoid another chaotic respiratory season. They are among the tools the new director of the Centers for Disease Control and Prevention says will help put the U.S. COVID-19 hospitalizations have been steadily increasing since late summer, although not nearly as much as this time last year, and RSV already is on the rise in parts of the Southeast.Īpproval of updated COVID-19 shots is expected within days.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |